

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.78926845 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.78926845 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.66618588 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.14348599 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.07068106 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.91371500 |
| 7 | positive thymic T cell selection (GO:0045059) | 4.86425526 |
| 8 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.76093229 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.71878710 |
| 10 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.50036031 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.41994171 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.41974022 |
| 13 | positive T cell selection (GO:0043368) | 4.37630956 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.36982406 |
| 15 | negative T cell selection (GO:0043383) | 4.36642407 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.30695123 |
| 17 | leukocyte aggregation (GO:0070486) | 4.30648938 |
| 18 | mannose metabolic process (GO:0006013) | 4.24201304 |
| 19 | thymic T cell selection (GO:0045061) | 4.22588998 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22409079 |
| 21 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.15715397 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14781622 |
| 23 | T cell selection (GO:0045058) | 4.03005381 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.93935365 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.93935365 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.93935365 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 3.93935365 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.93935365 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.93935365 |
| 30 | detection of other organism (GO:0098543) | 3.89143729 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.88810534 |
| 32 | detection of bacterium (GO:0016045) | 3.87868191 |
| 33 | interferon-gamma production (GO:0032609) | 3.79989887 |
| 34 | response to interleukin-15 (GO:0070672) | 3.78786497 |
| 35 | response to peptidoglycan (GO:0032494) | 3.78583028 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.75914760 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.70275060 |
| 38 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.67239277 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.62174218 |
| 40 | negative regulation of T cell mediated immunity (GO:0002710) | 3.58589002 |
| 41 | cellular extravasation (GO:0045123) | 3.51715466 |
| 42 | activated T cell proliferation (GO:0050798) | 3.48358181 |
| 43 | tolerance induction (GO:0002507) | 3.47266289 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 3.43287075 |
| 45 | adenosine receptor signaling pathway (GO:0001973) | 3.39384275 |
| 46 | cellular response to ATP (GO:0071318) | 3.38611461 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.33779697 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33281828 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.30718507 |
| 50 | negative regulation of innate immune response (GO:0045824) | 3.29296896 |
| 51 | T cell migration (GO:0072678) | 3.28130933 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 3.23547648 |
| 53 | GDP-mannose metabolic process (GO:0019673) | 3.16753632 |
| 54 | germinal center formation (GO:0002467) | 3.15936157 |
| 55 | negative regulation of interleukin-12 production (GO:0032695) | 3.14435855 |
| 56 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.13187208 |
| 57 | myeloid cell activation involved in immune response (GO:0002275) | 3.12027986 |
| 58 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.10459989 |
| 59 | response to type I interferon (GO:0034340) | 3.07062367 |
| 60 | regulation of B cell differentiation (GO:0045577) | 3.03395771 |
| 61 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03215122 |
| 62 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.99681024 |
| 63 | cellular response to type I interferon (GO:0071357) | 2.97427141 |
| 64 | type I interferon signaling pathway (GO:0060337) | 2.97427141 |
| 65 | purinergic receptor signaling pathway (GO:0035587) | 2.97165058 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 2.97129668 |
| 67 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.97035627 |
| 68 | leukocyte degranulation (GO:0043299) | 2.96847660 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 2.96670960 |
| 70 | detection of molecule of bacterial origin (GO:0032490) | 2.95599971 |
| 71 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.92425524 |
| 72 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.88860031 |
| 73 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87493833 |
| 74 | detection of biotic stimulus (GO:0009595) | 2.86478258 |
| 75 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.86423941 |
| 76 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.84105955 |
| 77 | defense response to protozoan (GO:0042832) | 2.79947734 |
| 78 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.78851421 |
| 79 | negative regulation of interleukin-8 production (GO:0032717) | 2.78486050 |
| 80 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78053095 |
| 81 | regulation of tolerance induction (GO:0002643) | 2.76514340 |
| 82 | regulation of granulocyte differentiation (GO:0030852) | 2.75400465 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 2.74867331 |
| 84 | immunoglobulin mediated immune response (GO:0016064) | 2.74367949 |
| 85 | T cell homeostasis (GO:0043029) | 2.71944316 |
| 86 | neutrophil activation (GO:0042119) | 2.69959329 |
| 87 | mast cell activation (GO:0045576) | 2.69937990 |
| 88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69830704 |
| 89 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.69285488 |
| 90 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.68696149 |
| 91 | positive regulation of interferon-alpha production (GO:0032727) | 2.67658471 |
| 92 | regulation of regulatory T cell differentiation (GO:0045589) | 2.65728145 |
| 93 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.65267915 |
| 94 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.65267915 |
| 95 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.65030748 |
| 96 | positive regulation of Rap GTPase activity (GO:0032854) | 2.64732235 |
| 97 | granulocyte activation (GO:0036230) | 2.64319319 |
| 98 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.64312480 |
| 99 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.63970007 |
| 100 | response to host immune response (GO:0052572) | 2.63970007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.28144655 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.46257480 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.16893637 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.12265238 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.83475104 |
| 6 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.80210414 |
| 7 | MAF_26560356_Chip-Seq_TH1_Human | 2.76509367 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.70978725 |
| 9 | MAF_26560356_Chip-Seq_TH2_Human | 2.66849865 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.61517655 |
| 11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.48382807 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47884031 |
| 13 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.45752688 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.43012764 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.42642957 |
| 16 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.42071599 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.41919236 |
| 18 | P68_20966046_ChIP-Seq_HELA_Human | 2.17610963 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.02118533 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00562352 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.95724011 |
| 22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.95409739 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94668146 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92581191 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89539700 |
| 26 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.88695892 |
| 27 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.84726015 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84331924 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77533712 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74333878 |
| 31 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.73134130 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71275585 |
| 33 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.70425610 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69761457 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67385103 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66111491 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.65696405 |
| 38 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.64704695 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61980351 |
| 40 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.58117921 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.57971756 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57110164 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.56636273 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.54510756 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.54002883 |
| 46 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.52436963 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52342696 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51874558 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.51815643 |
| 50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50600358 |
| 51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49840393 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47817067 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.45995239 |
| 54 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.45975234 |
| 55 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.45258271 |
| 56 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.44412427 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43063299 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42978261 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41822645 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41276665 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41202225 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.38616218 |
| 63 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36847322 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35273705 |
| 65 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.35005693 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33292465 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31203366 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30864763 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30601157 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30597825 |
| 71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28499823 |
| 72 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.28494651 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25298924 |
| 74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24671468 |
| 75 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.23327458 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22106417 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22029517 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22000440 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21493523 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20843545 |
| 81 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.20179795 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18436169 |
| 83 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17038537 |
| 84 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17009631 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15970921 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14259962 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13427651 |
| 88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13302588 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13270002 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12629154 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11890814 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11114992 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10241380 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09589474 |
| 95 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09391868 |
| 96 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09305439 |
| 97 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.09128060 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08176645 |
| 99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07827625 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07422021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001986_abnormal_taste_sensitivity | 4.08122317 |
| 2 | MP0003436_decreased_susceptibility_to | 3.68738293 |
| 3 | MP0003303_peritoneal_inflammation | 3.34948018 |
| 4 | MP0005174_abnormal_tail_pigmentation | 3.21115340 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.13856927 |
| 6 | MP0003724_increased_susceptibility_to | 3.09753302 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.88653028 |
| 8 | MP0004381_abnormal_hair_follicle | 2.87530076 |
| 9 | MP0001800_abnormal_humoral_immune | 2.68984896 |
| 10 | MP0005171_absent_coat_pigmentation | 2.48433407 |
| 11 | MP0005671_abnormal_response_to | 2.43549870 |
| 12 | MP0005025_abnormal_response_to | 2.35192635 |
| 13 | MP0000685_abnormal_immune_system | 2.35120427 |
| 14 | MP0009278_abnormal_bone_marrow | 2.34645263 |
| 15 | MP0002723_abnormal_immune_serum | 2.31796890 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.30536360 |
| 17 | MP0001790_abnormal_immune_system | 2.29974858 |
| 18 | MP0005387_immune_system_phenotype | 2.29974858 |
| 19 | MP0002419_abnormal_innate_immunity | 2.29551725 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.21621844 |
| 21 | MP0001819_abnormal_immune_cell | 2.19802013 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.19695720 |
| 23 | MP0005409_darkened_coat_color | 2.17649498 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.15090567 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.08958316 |
| 26 | MP0000015_abnormal_ear_pigmentation | 1.97719776 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.97324920 |
| 28 | MP0002398_abnormal_bone_marrow | 1.94771632 |
| 29 | MP0006082_CNS_inflammation | 1.91720880 |
| 30 | MP0001873_stomach_inflammation | 1.88092973 |
| 31 | MP0003136_yellow_coat_color | 1.86312057 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.84043366 |
| 33 | MP0002405_respiratory_system_inflammati | 1.81205988 |
| 34 | MP0000716_abnormal_immune_system | 1.79833415 |
| 35 | MP0004947_skin_inflammation | 1.73595664 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.70516813 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.69399974 |
| 38 | MP0009785_altered_susceptibility_to | 1.65450562 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.63607733 |
| 40 | MP0008260_abnormal_autophagy | 1.61781978 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.59333227 |
| 42 | MP0002722_abnormal_immune_system | 1.54052770 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.53001553 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.52748878 |
| 45 | MP0002429_abnormal_blood_cell | 1.49598514 |
| 46 | MP0004130_abnormal_muscle_cell | 1.47038879 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.45488288 |
| 48 | MP0001188_hyperpigmentation | 1.39880232 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.38070863 |
| 50 | MP0003866_abnormal_defecation | 1.36286709 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.35989811 |
| 52 | MP0002933_joint_inflammation | 1.34950394 |
| 53 | MP0005083_abnormal_biliary_tract | 1.34557593 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.25057938 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.23275927 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.23275927 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.22426292 |
| 58 | MP0005451_abnormal_body_composition | 1.21555520 |
| 59 | MP0002132_abnormal_respiratory_system | 1.13107627 |
| 60 | MP0008469_abnormal_protein_level | 1.11235027 |
| 61 | MP0005310_abnormal_salivary_gland | 1.10924492 |
| 62 | MP0000858_altered_metastatic_potential | 1.09871883 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.05124000 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 0.93792186 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 0.93134084 |
| 66 | MP0002998_abnormal_bone_remodeling | 0.91932237 |
| 67 | MP0001851_eye_inflammation | 0.91864679 |
| 68 | MP0001502_abnormal_circadian_rhythm | 0.89878995 |
| 69 | MP0003448_altered_tumor_morphology | 0.89311671 |
| 70 | MP0002019_abnormal_tumor_incidence | 0.87324171 |
| 71 | MP0003828_pulmonary_edema | 0.87275245 |
| 72 | MP0009764_decreased_sensitivity_to | 0.86166439 |
| 73 | MP0001968_abnormal_touch/_nociception | 0.84551035 |
| 74 | MP0003091_abnormal_cell_migration | 0.83934749 |
| 75 | MP0002009_preneoplasia | 0.82141050 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.80528163 |
| 77 | MP0001663_abnormal_digestive_system | 0.79574254 |
| 78 | MP0001765_abnormal_ion_homeostasis | 0.79546588 |
| 79 | MP0002166_altered_tumor_susceptibility | 0.78967296 |
| 80 | MP0003183_abnormal_peptide_metabolism | 0.78307237 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.74823952 |
| 82 | MP0004510_myositis | 0.72358571 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.70003508 |
| 84 | MP0003045_fibrosis | 0.69608005 |
| 85 | MP0003690_abnormal_glial_cell | 0.69583514 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66925482 |
| 87 | MP0000470_abnormal_stomach_morphology | 0.66856137 |
| 88 | MP0001756_abnormal_urination | 0.66584589 |
| 89 | MP0008874_decreased_physiological_sensi | 0.65186744 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.64430739 |
| 91 | MP0009931_abnormal_skin_appearance | 0.64215554 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.64131885 |
| 93 | MP0004883_abnormal_blood_vessel | 0.63828008 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.63762157 |
| 95 | MP0005166_decreased_susceptibility_to | 0.61416537 |
| 96 | MP0001958_emphysema | 0.61318574 |
| 97 | MP0009840_abnormal_foam_cell | 0.60769439 |
| 98 | MP0004043_abnormal_pH_regulation | 0.58285822 |
| 99 | MP0001853_heart_inflammation | 0.57093603 |
| 100 | MP0000490_abnormal_crypts_of | 0.55468819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.89017731 |
| 2 | Pustule (HP:0200039) | 4.09542784 |
| 3 | Myositis (HP:0100614) | 4.03637801 |
| 4 | Gastrointestinal infarctions (HP:0005244) | 3.96037455 |
| 5 | Thin bony cortex (HP:0002753) | 3.92924314 |
| 6 | Annular pancreas (HP:0001734) | 3.89098706 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.82237188 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.76766288 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.75551320 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.64761631 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.54785085 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.47843859 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.47843859 |
| 14 | Orchitis (HP:0100796) | 3.36117349 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.25534657 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 3.22606144 |
| 17 | Testicular atrophy (HP:0000029) | 3.21871514 |
| 18 | Rib fusion (HP:0000902) | 3.16201106 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.15447032 |
| 20 | Optic neuritis (HP:0100653) | 3.15447032 |
| 21 | Hemorrhage of the eye (HP:0011885) | 3.15194238 |
| 22 | Poikiloderma (HP:0001029) | 3.14209816 |
| 23 | Stomatitis (HP:0010280) | 3.13086432 |
| 24 | Intestinal fistula (HP:0100819) | 3.10441322 |
| 25 | Hypochromic anemia (HP:0001931) | 3.09883918 |
| 26 | Meningitis (HP:0001287) | 3.07259905 |
| 27 | Abnormality of the fingertips (HP:0001211) | 3.00439674 |
| 28 | Recurrent skin infections (HP:0001581) | 3.00322920 |
| 29 | Basal cell carcinoma (HP:0002671) | 2.86259117 |
| 30 | Obstructive lung disease (HP:0006536) | 2.83572259 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83572259 |
| 32 | Colitis (HP:0002583) | 2.78293406 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 2.76238169 |
| 34 | Ulnar bowing (HP:0003031) | 2.74466753 |
| 35 | Increased IgE level (HP:0003212) | 2.73558542 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.73458166 |
| 37 | Facial hemangioma (HP:0000329) | 2.69611416 |
| 38 | Encephalitis (HP:0002383) | 2.67532150 |
| 39 | T lymphocytopenia (HP:0005403) | 2.65441408 |
| 40 | Recurrent viral infections (HP:0004429) | 2.60229343 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60103435 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 2.59931334 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.58741238 |
| 44 | Facial diplegia (HP:0001349) | 2.58378655 |
| 45 | Attenuation of retinal blood vessels (HP:0007843) | 2.51808405 |
| 46 | Chest pain (HP:0100749) | 2.50579792 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.50239740 |
| 48 | Vasculitis (HP:0002633) | 2.49413417 |
| 49 | Rectal fistula (HP:0100590) | 2.47851509 |
| 50 | Rectovaginal fistula (HP:0000143) | 2.47851509 |
| 51 | Epistaxis (HP:0000421) | 2.47370727 |
| 52 | Congenital stationary night blindness (HP:0007642) | 2.41209294 |
| 53 | Squamous cell carcinoma (HP:0002860) | 2.39092707 |
| 54 | Anorexia (HP:0002039) | 2.35885838 |
| 55 | Abnormality of T cells (HP:0002843) | 2.35766025 |
| 56 | Vaginal fistula (HP:0004320) | 2.35163648 |
| 57 | Turricephaly (HP:0000262) | 2.34872190 |
| 58 | Granulocytopenia (HP:0001913) | 2.34822129 |
| 59 | Hemoptysis (HP:0002105) | 2.34164477 |
| 60 | Joint hemorrhage (HP:0005261) | 2.32528376 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.31866513 |
| 62 | Cheilitis (HP:0100825) | 2.31051465 |
| 63 | Cellulitis (HP:0100658) | 2.30924179 |
| 64 | Papilledema (HP:0001085) | 2.28421910 |
| 65 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27713927 |
| 66 | Gingivitis (HP:0000230) | 2.24565210 |
| 67 | Joint stiffness (HP:0001387) | 2.22697888 |
| 68 | Increased serum ferritin (HP:0003281) | 2.18003099 |
| 69 | Dyschromatopsia (HP:0007641) | 2.13284430 |
| 70 | Akinesia (HP:0002304) | 2.12629061 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11990377 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11990377 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11990377 |
| 74 | Easy fatigability (HP:0003388) | 2.11444852 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 2.11420704 |
| 76 | Anteriorly placed anus (HP:0001545) | 2.08774659 |
| 77 | Keratoconjunctivitis (HP:0001096) | 2.08216021 |
| 78 | Agammaglobulinemia (HP:0004432) | 2.06783983 |
| 79 | Mucopolysacchariduria (HP:0008155) | 2.04659648 |
| 80 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04659648 |
| 81 | Premature graying of hair (HP:0002216) | 2.04634212 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.03414718 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.02469240 |
| 84 | Arterial thrombosis (HP:0004420) | 2.02029705 |
| 85 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.00121174 |
| 86 | Short chin (HP:0000331) | 2.00033684 |
| 87 | Slow saccadic eye movements (HP:0000514) | 1.96018607 |
| 88 | Leukocytosis (HP:0001974) | 1.94134524 |
| 89 | Emphysema (HP:0002097) | 1.92518026 |
| 90 | Papilloma (HP:0012740) | 1.92103995 |
| 91 | Verrucae (HP:0200043) | 1.92103995 |
| 92 | Ocular albinism (HP:0001107) | 1.90913758 |
| 93 | Malnutrition (HP:0004395) | 1.90554906 |
| 94 | Abnormality of the costochondral junction (HP:0000919) | 1.90323836 |
| 95 | Nasal polyposis (HP:0100582) | 1.88510893 |
| 96 | Dysostosis multiplex (HP:0000943) | 1.87346710 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.86735195 |
| 98 | Obstructive sleep apnea (HP:0002870) | 1.86353911 |
| 99 | Enlarged epiphyses (HP:0010580) | 1.82790634 |
| 100 | Dislocated radial head (HP:0003083) | 1.81536794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.92598931 |
| 2 | BLK | 3.05893927 |
| 3 | RIPK4 | 3.01121726 |
| 4 | PRPF4B | 2.74108254 |
| 5 | MAPK15 | 2.71927005 |
| 6 | MAP2K3 | 2.71184002 |
| 7 | GRK6 | 2.67290228 |
| 8 | ERN1 | 2.63771820 |
| 9 | TRIB3 | 2.60353527 |
| 10 | ZAP70 | 2.34911636 |
| 11 | TYK2 | 2.06108166 |
| 12 | TXK | 2.04895956 |
| 13 | TNK2 | 2.03278706 |
| 14 | SIK2 | 2.02052934 |
| 15 | CSK | 1.88734910 |
| 16 | FES | 1.84781467 |
| 17 | IRAK4 | 1.79157206 |
| 18 | SIK1 | 1.77535231 |
| 19 | BTK | 1.65136287 |
| 20 | JAK3 | 1.53626795 |
| 21 | IKBKE | 1.53467574 |
| 22 | EPHB1 | 1.42215832 |
| 23 | MAP3K13 | 1.41926457 |
| 24 | TBK1 | 1.41466768 |
| 25 | SYK | 1.39529129 |
| 26 | MAP3K14 | 1.37841254 |
| 27 | MARK2 | 1.37550631 |
| 28 | ITK | 1.30828111 |
| 29 | CDK12 | 1.29008375 |
| 30 | HCK | 1.27701367 |
| 31 | SMG1 | 1.24884057 |
| 32 | PRKD2 | 1.24388439 |
| 33 | SIK3 | 1.20806610 |
| 34 | TESK2 | 1.19355559 |
| 35 | JAK1 | 1.12749243 |
| 36 | MAPK12 | 1.11883201 |
| 37 | MAP3K3 | 1.10283416 |
| 38 | MAP3K11 | 1.09236273 |
| 39 | WNK4 | 1.05976103 |
| 40 | LCK | 1.03462195 |
| 41 | MAP3K10 | 1.02131526 |
| 42 | LYN | 1.01809185 |
| 43 | FGFR4 | 0.99915479 |
| 44 | MAP3K7 | 0.99092395 |
| 45 | EEF2K | 0.98800043 |
| 46 | CDC42BPA | 0.98469503 |
| 47 | IKBKB | 0.97152464 |
| 48 | TAOK1 | 0.95870747 |
| 49 | PDPK1 | 0.95323280 |
| 50 | CDK4 | 0.93878005 |
| 51 | IRAK2 | 0.93164447 |
| 52 | MAP2K6 | 0.93115287 |
| 53 | ICK | 0.91315836 |
| 54 | HIPK2 | 0.91252714 |
| 55 | TAOK3 | 0.90361928 |
| 56 | MAPK11 | 0.89223402 |
| 57 | CAMKK1 | 0.87959001 |
| 58 | MAP3K1 | 0.86253266 |
| 59 | JAK2 | 0.82599903 |
| 60 | PDK1 | 0.81866453 |
| 61 | MARK3 | 0.80807059 |
| 62 | PTK6 | 0.79354443 |
| 63 | TLK1 | 0.78399575 |
| 64 | KIT | 0.77082673 |
| 65 | WNK1 | 0.75773024 |
| 66 | TEC | 0.75690295 |
| 67 | CSF1R | 0.75677780 |
| 68 | PKN2 | 0.70289580 |
| 69 | RPS6KL1 | 0.69690268 |
| 70 | RPS6KC1 | 0.69690268 |
| 71 | DYRK1B | 0.69574379 |
| 72 | KSR2 | 0.69218807 |
| 73 | RPS6KA6 | 0.68990918 |
| 74 | STK11 | 0.68552492 |
| 75 | FGFR3 | 0.67938524 |
| 76 | MAPK7 | 0.63743628 |
| 77 | MELK | 0.60109820 |
| 78 | PRKCQ | 0.58095318 |
| 79 | TYRO3 | 0.57006480 |
| 80 | MAP3K6 | 0.55155164 |
| 81 | CDK6 | 0.54402986 |
| 82 | RPS6KA2 | 0.53893448 |
| 83 | FGR | 0.53883269 |
| 84 | MAP2K2 | 0.53409790 |
| 85 | RET | 0.51181919 |
| 86 | PRKCH | 0.48549343 |
| 87 | PIM1 | 0.48503647 |
| 88 | IRAK1 | 0.47232554 |
| 89 | BMX | 0.45940141 |
| 90 | RIPK1 | 0.45782617 |
| 91 | PRKD1 | 0.44788371 |
| 92 | SGK3 | 0.43177454 |
| 93 | STK10 | 0.42850277 |
| 94 | CHUK | 0.41984023 |
| 95 | STK38 | 0.40709332 |
| 96 | DAPK2 | 0.38559700 |
| 97 | MTOR | 0.38431280 |
| 98 | FYN | 0.37340300 |
| 99 | ACVR1B | 0.36939859 |
| 100 | IRAK3 | 0.36655341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.84355783 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.41333820 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28407444 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18070783 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04573689 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.03948434 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.95441559 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.89278460 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.87136618 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.85338433 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 1.79939872 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.76360388 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73115813 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.72393993 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68925919 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65155063 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64459598 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64038700 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61278078 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59267514 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52146088 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50742202 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.49070283 |
| 24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.47397893 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.45886668 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.45658043 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37718097 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35401049 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32047213 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31972742 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.30901670 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30880875 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28019644 |
| 34 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.26173797 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.18887199 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.18603640 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18175258 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16635860 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.15083314 |
| 40 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.13736122 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12529184 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12442373 |
| 43 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12150575 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12121024 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12018199 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10753041 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.06918828 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06822201 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.05212069 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00886336 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.99400224 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99187214 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97709832 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96004416 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91719801 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89499315 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88695126 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86247706 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84668152 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.82375685 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81614385 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81079760 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.78764910 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77069948 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76892430 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.75737049 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75573704 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75015105 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73449108 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73213316 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72459243 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.70705796 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70562369 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70048736 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69514355 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68574532 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.67566463 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.67075474 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65819152 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64664183 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63803063 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60501179 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59520369 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57023054 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54201523 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52452056 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.51616591 |
| 88 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.49645607 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.47462868 |
| 90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47353209 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47294722 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.45347431 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45178543 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45118344 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45018899 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.42240457 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.40228958 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39836728 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39615502 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39461976 |

